Cargando…

Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?

Detalles Bibliográficos
Autores principales: Lesueur, Paul, Kao, William, Geffrelot, Julien, Stefan, Dinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798134/
https://www.ncbi.nlm.nih.gov/pubmed/35117683
http://dx.doi.org/10.21037/tcr.2020.04.15
_version_ 1784641726167646208
author Lesueur, Paul
Kao, William
Geffrelot, Julien
Stefan, Dinu
author_facet Lesueur, Paul
Kao, William
Geffrelot, Julien
Stefan, Dinu
author_sort Lesueur, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-8798134
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87981342022-02-02 Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? Lesueur, Paul Kao, William Geffrelot, Julien Stefan, Dinu Transl Cancer Res Editorial Commentary AME Publishing Company 2020-05 /pmc/articles/PMC8798134/ /pubmed/35117683 http://dx.doi.org/10.21037/tcr.2020.04.15 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial Commentary
Lesueur, Paul
Kao, William
Geffrelot, Julien
Stefan, Dinu
Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title_full Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title_fullStr Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title_full_unstemmed Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title_short Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
title_sort adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798134/
https://www.ncbi.nlm.nih.gov/pubmed/35117683
http://dx.doi.org/10.21037/tcr.2020.04.15
work_keys_str_mv AT lesueurpaul adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated
AT kaowilliam adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated
AT geffrelotjulien adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated
AT stefandinu adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated